Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 22 04:00PM ET
131.10
Dollar change
+0.34
Percentage change
0.26
%
IndexDJIA, S&P 500 P/E145.94 EPS (ttm)0.90 Insider Own0.12% Shs Outstand2.53B Perf Week-0.48%
Market Cap332.05B Forward P/E13.20 EPS next Y9.94 Insider Trans-11.88% Shs Float2.53B Perf Month3.33%
Income2.31B PEG- EPS next Q2.14 Inst Own79.11% Short Float0.74% Perf Quarter1.42%
Sales61.09B P/S5.44 EPS this Y473.13% Inst Trans0.64% Short Ratio2.28 Perf Half Y27.68%
Book/sh15.94 P/B8.23 EPS next Y14.80% ROA2.16% Short Interest18.75M Perf Year14.51%
Cash/sh2.25 P/C58.14 EPS next 5Y- ROE5.29% 52W Range99.14 - 133.10 Perf YTD20.25%
Dividend Est.3.16 (2.41%) P/FCF30.08 EPS past 5Y-42.70% ROI3.22% 52W High-1.50% Beta0.41
Dividend TTM3.00 (2.29%) Quick Ratio0.99 Sales past 5Y7.72% Gross Margin71.63% 52W Low32.24% ATR (14)1.88
Dividend Ex-DateMar 14, 2024 Current Ratio1.25 EPS Y/Y TTM-82.24% Oper. Margin8.23% RSI (14)58.91 Volatility1.13% 1.50%
Employees72000 Debt/Eq0.85 Sales Y/Y TTM7.01% Profit Margin3.77% Recom1.52 Target Price144.01
Option/ShortYes / Yes LT Debt/Eq0.77 EPS Q/Q69.28% Payout2065.60% Rel Volume0.54 Prev Close130.76
Sales Surprise3.75% EPS Surprise9.79% Sales Q/Q8.38% EarningsApr 25 BMO Avg Volume8.21M Price131.10
SMA201.07% SMA502.89% SMA20013.93% Trades Volume4,397,457 Change0.26%
Date Action Analyst Rating Change Price Target Change
Mar-11-24Downgrade Societe Generale Hold → Sell $104
Jan-04-24Upgrade TD Cowen Market Perform → Outperform $125 → $135
Nov-09-23Initiated Deutsche Bank Buy $115
Oct-27-23Upgrade BMO Capital Markets Market Perform → Outperform $132
Oct-20-23Upgrade UBS Neutral → Buy $117 → $122
Jul-14-23Initiated HSBC Securities Hold $123
Apr-13-23Upgrade Citigroup Neutral → Buy $105 → $130
Mar-28-23Downgrade Societe Generale Buy → Hold
Mar-13-23Downgrade Wells Fargo Overweight → Equal Weight $120 → $115
Mar-06-23Initiated Jefferies Buy $125
Today 09:50AM
May-20-24 09:14AM
May-17-24 06:00AM
May-16-24 10:51AM
09:35AM
06:45AM Loading…
May-15-24 06:45AM
May-14-24 09:25AM
05:21AM
May-13-24 01:09PM
06:45AM
May-10-24 06:30AM
06:01AM
May-09-24 09:00AM
07:05AM
06:45AM
09:15AM Loading…
May-08-24 09:15AM
08:30AM
06:56AM
06:45AM
May-07-24 02:49PM
May-06-24 02:30PM
10:50AM
08:11AM
May-03-24 09:50AM
May-02-24 02:53PM
May-01-24 06:52PM
07:15AM
06:24AM
Apr-30-24 08:44AM
Apr-29-24 09:00AM
06:54PM Loading…
Apr-28-24 06:54PM
Apr-27-24 09:14AM
Apr-26-24 10:59AM
Apr-25-24 05:54PM
04:09PM
03:30PM
02:29PM
12:52PM
12:09PM
11:42AM
11:34AM
11:23AM
10:54AM
10:30AM
09:13AM
09:13AM
07:30AM
07:04AM
06:44AM
06:33AM
06:30AM
06:30AM
Apr-24-24 05:50PM
Apr-23-24 07:49AM
Apr-22-24 02:39PM
11:10AM
09:15AM
Apr-21-24 10:49AM
Apr-19-24 07:04AM
Apr-18-24 04:27PM
10:01AM
Apr-17-24 05:50PM
08:00AM
Apr-16-24 03:17PM
Apr-15-24 07:48AM
Apr-12-24 06:40AM
Apr-11-24 05:50PM
Apr-08-24 11:38PM
02:00PM
Apr-07-24 02:00PM
Apr-06-24 08:47PM
Apr-05-24 05:45PM
05:33AM
Apr-04-24 07:38AM
06:45AM
05:36AM
Apr-03-24 05:50PM
08:00AM
Apr-01-24 09:50AM
06:45AM
Mar-29-24 10:51AM
Mar-28-24 05:50PM
09:15AM
06:45AM
Mar-27-24 04:36PM
04:00PM
02:58PM
12:20PM
11:54AM
10:58AM
10:26AM
10:10AM
09:53AM
09:00AM
08:50AM
08:39AM
07:36AM
07:36AM
Mar-26-24 06:21PM
05:07PM
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 04 '24Option Exercise127.5127,1263,458,836163,720May 06 04:08 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketMay 04 '24Option Exercise127.51912116,28924,271May 06 04:01 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 04 '24Option Exercise127.51887113,10124,058May 06 04:06 PM
Smart DaltonSVP Fin. - Global ControllerMay 04 '24Option Exercise127.5161278,0364,730May 06 04:10 PM
Smart DaltonSVP Fin. - Global ControllerMay 03 '24Option Exercise128.262,046262,4204,708May 06 04:10 PM
Romanelli JosephPresident, Human Health Int?lMay 02 '24Option Exercise128.802,262291,34621,831May 02 04:29 PM
Smart DaltonSVP Fin. - Global ControllerMay 02 '24Option Exercise128.8038149,0733,048May 02 04:23 PM
Merck & Co., Inc.10% OwnerMar 11 '24Buy23.0021,397,205492,135,7151,000Mar 11 03:27 PM
Davis Robert MChairman, CEO & PresidentFeb 14 '24Option Exercise73.7385,0216,268,598433,348Feb 15 04:01 PM
Litchfield CarolineEVP & CFOFeb 14 '24Option Exercise58.0838,2912,223,94189,199Feb 15 04:03 PM
Davis Robert MChairman, CEO & PresidentFeb 14 '24Sale125.4085,02110,661,574348,327Feb 15 04:01 PM
Litchfield CarolineEVP & CFOFeb 14 '24Sale125.5038,2914,805,52050,908Feb 15 04:03 PM
Davis Robert MChairman, CEO & PresidentFeb 13 '24Option Exercise74.18150,00011,127,160498,327Feb 15 04:01 PM
Davis Robert MChairman, CEO & PresidentFeb 13 '24Sale125.85150,00018,877,424348,327Feb 15 04:01 PM
Romanelli JosephPresident, Human Health Int?lFeb 13 '24Sale124.891,000124,88819,569Feb 14 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09 '24Option Exercise62.0714,702912,55360,944Feb 12 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09 '24Sale125.5014,7021,845,08346,242Feb 12 04:03 PM
Williams David MichaelEVP,Chief Info&Digital OfficerFeb 07 '24Sale127.571,451185,10819,812Feb 08 04:04 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02 '24Option Exercise73.6532,9942,430,15974,313Feb 02 04:07 PM
Zachary JenniferEVP, General CounselFeb 02 '24Option Exercise87.1019,4171,691,22178,557Feb 02 04:05 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02 '24Option Exercise78.8020,9371,649,90642,286Feb 05 04:01 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02 '24Sale126.6550,6946,420,34923,619Feb 02 04:07 PM
Zachary JenniferEVP, General CounselFeb 02 '24Sale126.9749,4996,284,77929,058Feb 02 04:05 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02 '24Sale127.1718,9592,411,11123,327Feb 05 04:01 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketNov 09 '23Sale102.382,081213,06118,191Nov 13 07:36 AM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthNov 08 '23Sale105.0343,8234,602,668111,764Nov 09 09:04 AM
Oosthuizen Johannes JacobusPresident, U.S. MarketOct 30 '23Option Exercise102.8291594,08020,723Oct 31 11:08 AM
MIZELL STEVENEVP, Chief HR OfficerAug 14 '23Sale109.014,250463,29222,935Aug 15 04:08 PM
Guindo ChirfiChief Marketing OfficerAug 03 '23Option Exercise105.7036,9013,900,43638,342Aug 04 04:17 PM
MIZELL STEVENEVP, Chief HR OfficerAug 03 '23Sale105.494,500474,70127,185Aug 04 04:06 PM
Romanelli JosephPresident, Human Health Int?lAug 02 '23Sale107.37596,3350Aug 03 04:08 PM
Romanelli JosephPresident, Human Health Int?lAug 02 '23Sale107.37303,22120,569Aug 03 04:08 PM